カテゴリ： MarketLine, イギリス, 企業調査

Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務分析

◆英語タイトル：Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4495
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report
Summary

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hikma Pharmaceuticals (Hikma or ‘the company’) is engaged in the development, manufacturing and marketing of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including: anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various dosage forms such as solutions, suspensions and capsules and tablets. The company markets its products under brands such as Amoclan, Blopress, Suprax, Omnicef, Prograf, Suprax and Cresemba. The company primarily operates in the Middle East, North the US, Europe and Africa. The company is headquartered in London, the UK.

Scope

- Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
- An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
- Intelligence on Hikma Pharmaceuticals PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hikma Pharmaceuticals PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Hikma Pharmaceuticals PLC: Company Overview
Hikma Pharmaceuticals PLC: Overview and Key Facts
Hikma Pharmaceuticals PLC: Overview
Hikma Pharmaceuticals PLC: Key Facts
Hikma Pharmaceuticals PLC: Key Employees
Hikma Pharmaceuticals PLC: Key Employee Biographies
Hikma Pharmaceuticals PLC: Major Products and Services
Hikma Pharmaceuticals PLC: Company History
Hikma Pharmaceuticals PLC: Management Statement
Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Hikma Pharmaceuticals PLC: Key Competitors
Hikma Pharmaceuticals PLC: Company Analysis
Hikma Pharmaceuticals PLC: Business Description
Hikma Pharmaceuticals PLC: SWOT Analysis
Hikma Pharmaceuticals PLC: SWOT Overview
Hikma Pharmaceuticals PLC: Strengths
Hikma Pharmaceuticals PLC: Weaknesses
Hikma Pharmaceuticals PLC: Opportunities
Hikma Pharmaceuticals PLC: Threats
Hikma Pharmaceuticals PLC: Corporate Financial Deals Activity
Hikma Pharmaceuticals PLC: Financial Deals Overview
Hikma Pharmaceuticals PLC: Targets and Partners
Hikma Pharmaceuticals PLC: Top Deals 2016 – 2020YTD*
Hikma Pharmaceuticals PLC: Advisors
Hikma Pharmaceuticals PLC: Top Legal Advisors
Hikma Pharmaceuticals PLC: Mergers and Acquisitions
Hikma Pharmaceuticals PLC: Partnership
Hikma Pharmaceuticals PLC: Recent Developments
Hikma Pharmaceuticals PLC: News and Events Summary
Hikma Pharmaceuticals PLC: Contracts
Hikma Pharmaceuticals PLC: Corporate Governance
Hikma Pharmaceuticals PLC: Financial Deals
Hikma Pharmaceuticals PLC: Financial Performance
Hikma Pharmaceuticals PLC: Market Developments
Hikma Pharmaceuticals PLC: Research & Development
Hikma Pharmaceuticals PLC: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Hikma Pharmaceuticals PLC: Key Facts
Table 2: Hikma Pharmaceuticals PLC: Key Employees
Table 3: Hikma Pharmaceuticals PLC: Company History
Table 4: Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Table 5: Hikma Pharmaceuticals PLC: Key Competitors
Table 6: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Table 9: Hikma Pharmaceuticals PLC: Targets and Partners
Table 10: Hikma Pharmaceuticals PLC: Top Deals 2016 - 2020YTD*
Table 11: Hikma Pharmaceuticals PLC: Legal Advisor Ranking by Value (US$m)
Table 12: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 15: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 16: Hikma Pharmaceuticals PLC: News and Events Summary
Table 17: Hikma Pharmaceuticals PLC: Contracts
Table 18: Hikma Pharmaceuticals PLC: Corporate Governance
Table 19: Hikma Pharmaceuticals PLC: Financial Deals
Table 20: Hikma Pharmaceuticals PLC: Financial Performance
Table 21: Hikma Pharmaceuticals PLC: Market Developments
Table 22: Hikma Pharmaceuticals PLC: Research & Development
Table 23: Hikma Pharmaceuticals PLC: Strategy and Operations

★海外企業調査レポート[Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Ebro Foods SA：企業のM&A・事業提携・投資動向
    Ebro Foods SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ebro Foods SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • QinetiQ Group Plc：企業の戦略・SWOT・財務情報
    QinetiQ Group Plc - Strategy, SWOT and Corporate Finance Report Summary QinetiQ Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Frontline Ltd (FRO)：石油・ガス：M&Aディール及び事業提携情報
    Summary Frontline Ltd (Frontline) is a shipping company. It transports crude oil and its related refined petroleum products. The company owns and operates very large crude carriers (VLCCs), Suezmax tankers, and Aframax/LR2 tankers. Its vessels operate in the spot and time charter markets. Frontline’ …
  • Empresa Nacional del Petroleo：企業の戦略的SWOT分析
    Empresa Nacional del Petroleo - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Indigo Books & Music, Inc.：戦略・SWOT・企業財務分析
    Indigo Books & Music, Inc. - Strategy, SWOT and Corporate Finance Report Summary Indigo Books & Music, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Toto Ltd：企業の戦略・SWOT・財務情報
    Toto Ltd - Strategy, SWOT and Corporate Finance Report Summary Toto Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • New China Life Insurance Company Ltd.：戦略・SWOT・企業財務分析
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • David Lloyd Leisure Ltd：企業の戦略・SWOT・財務情報
    David Lloyd Leisure Ltd - Strategy, SWOT and Corporate Finance Report Summary David Lloyd Leisure Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Siemens Healthineers.：企業のM&A・事業提携・投資動向
    Siemens Healthineers. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens Healthineers. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • MicuRx Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …
  • Federal Electricity & Water Authority：企業の戦略的SWOT分析
    Federal Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Vestas Wind Systems A/S：企業の戦略・SWOT・財務情報
    Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report Summary Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Basin Electric Power Coop：企業の発電所・SWOT分析2018
    Basin Electric Power Coop - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Crane Co：企業の戦略・SWOT・財務分析
    Crane Co - Strategy, SWOT and Corporate Finance Report Summary Crane Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Extendicare Inc (EXE)：企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • ScinoPharm Taiwan Ltd (1789)：企業の財務・戦略的SWOT分析
    ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Chubu Electric Power Co Inc (9502)-エネルギー分野：企業M&A・提携分析
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity from nuclear, hydro, solar, biomass, wind, coal, fuel oil, and natural gas sources. Chubu has interests in upstream …
  • Eddie Stobart Logistics plc：企業の戦略・SWOT・財務情報
    Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Orthofix International N.V. (OFIX)-医療機器分野：企業M&A・提携分析
    Summary Orthofix International N.V. (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic. Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation prod …
  • National Insurance Corporation of Eritrea Share Company：企業の戦略的SWOT分析
    National Insurance Corporation of Eritrea Share Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key c …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆